[an error occurred while processing this directive] | [an error occurred while processing this directive]
Evaluation and prediction of pelvic dose in postoperative IMRT for cervical cancer
Sun Yanze, Yang Yongqiang, Qian Jianjun, Tian Ye
Department of Radiation Oncology,Second Affiliated Hospital of Soochow University;Institute of Radiotherapy& Oncology,Soochow University;Suzhou Key Laboratory for Radiation Oncology,Suzhou 215004,China
AbstractObjective To evaluate and predict the pelvic dose by analyzing two pelvic contour definitions and identify the influencing factors of the pelvic dose in postoperative IMRT for cervical cancer, aiming to provide reference for postoperative pelvis-sparing IMRT for cervical cancer. Methods Sixty cervical cancer patients receiving postoperative IMRT with unrestricted pelvic dose were selected. Two sets of pelvic contours (pelvic anatomy and pelvic Mell) were delineated as per the anatomical and Mell methods. The dose relationship between two methods was analyzed after redesigning the treatment plan by limiting dose of pelvic anatomy. The correlation analysis was performed by Pearson’s correlation method. The factors affecting the pelvic anatomy dose were identified by Logistic multivariate regression analysis and a dose prediction model was subsequently established. Results The volumes of pelvic anatomy and pelvic Mell were 925.82 cm3 and 1141.20 cm3(P=0.000). There was a significant correlation between them (r>0.622,P=0.000). The dose of pelvic anatomy was significantly higher than that of pelvic Mell. The relationship of V10,V20 and V30 between them was y=-8+1.01x,y=-13+1.05x and y=-4+0.9x, respectively. The dose limits of pelvic Mell recommended by literatures(V10<90%,V20<75%,V30<60%) were translated into V10<97%,V20<83% and V30<70%, respectively. The pelvic anatomy dose was significantly reduced after dose limiting. The V10,V20,V30 and Dmean were significantly decreased by 3.64%,12.69%,12.02% and 6.93%(P=0.000,0.000,0.000), respectively. Multivariate analysis showed that the overlapping volume of pelvic anatomy within PTV was an independent influencing factor of pelvic anatomy dose (P<0.05). Patients with a relative overlapping volume of less than 18% could easily meet the dose limiting requirement. Conclusions Both two pelvic contour definitions can be applied in postoperative pelvis-sparing IMRT for cervical cancer. Use of pelvic dose limiting can significantly reduce the IMRT dose. The overlapping volume of the pelvis within PTV is an independent influencing factor of pelvic dose. Patients whose overlapping volume within the PTV relative to pelvis is less than 18% can easily meet the dose limiting requirement.
Fund:Jiangsu Medical Innovation Team (CXTD-37);Jiangsu Key Research& Development Project (BE2018657);Suzhou Clinical Medicine Center Construction Project (SZZXJ201503);Suzhou Youth Science and Technology Project (KJXW2016010)
Sun Yanze,Yang Yongqiang,Qian Jianjun et al. Evaluation and prediction of pelvic dose in postoperative IMRT for cervical cancer[J]. Chinese Journal of Radiation Oncology, 2020, 29(2): 136-140.
Sun Yanze,Yang Yongqiang,Qian Jianjun et al. Evaluation and prediction of pelvic dose in postoperative IMRT for cervical cancer[J]. Chinese Journal of Radiation Oncology, 2020, 29(2): 136-140.
[1] Mell LK,Kochanski JD,Roeske JC,et al. Dosimetric predictors of acute hematologic toxicity in cervical cancer patients treated with concurrent cisplatin and intensity-modulated pelvic radiotherapy[J]. Int J Radiat Oncol Biol Phys,2006,66(5):1356-1365. DOI:10.1016/j.ijrobp.2006.03.018.
[2] Rose BS,Aydogan B,Liang Y,et al.Normal tissue complication probability modeling of acute hematologic toxicity in cervical cancer patients treated with chemoradiotherapy[J]. Int J Radiat 0ncol Biol Phys,2011,79(3):800-807. DOI:10.1016/j.ijrobp.2009.11.010.
[3] Sanford L,Molloy J,Kumar S,et al. Evaluation of plan quality and treatment efficiency for single-isocenter/two-lesion lung stereotactic body radiation therapy[J]. J Appl Clin Med Phys,2019,20(1):118-127. DOI:10.1002/acm2.12500.
[4] Yang Y,Li W,Qian J,et al. Dosimetric predictors of acute hematologic toxicity due to intensity-modulated pelvic radiotherapy with concurrent chemotherapy for pelvic cancer patients[J]. Transl Cancer Res,2018,7(3):515-523. DOI:10.21037/ tcr.2018.05.04.
[5] Hall E,Giaccia A. Clinical response of normal tissues[A]//Hall EJ,Giaccia AJ. Radiobiology for the radiologist[M].6th ed. Philadelphia:Lippincott Williams& Wilkins,2006:333-337,461-332.
[6] Wan J,Liu K,Li K,et al. Can dosimetric parameters predict acute hematologic toxicity in rectal cancer patients treated with intensity-modulated pelvic radiotherapy?[J]. Radiat Oncol,2015,10(1):162. DOI:10.1186/s13014-015-0454-0.
[7] 张道明,国慧,张奇,等. 宫颈癌术后放疗行限定骨盆IMRT计划剂量学分析[J]. 中华放射肿瘤学杂志,2017,26(11):1303-1307. DOI:10.3760/cma.j.issn.1004-4221.2017.11.013.
Zhang DM,Guo H,Zhang Q,et al. Dosimetric analysis of bone marrow-sparing pelvic intensity-modulated radiotherapy after surgery for cervical cancer[J]. Chin J Radiat Oncol,2017,26(11):1303-1307. DOI:10.3760/cma.j.issn.1004-4221.2017.11.013.
[8] Li N,Noticewala SS,Williamson CW,et al. Feasibility of atlas-based active bone marrow sparing intensity modulated radiation therapy for cervical cancer[J]. Radiother Oncol,2017,123(2):325-330. DOI:10.1016/j.radonc.2017.02.017.
2020, Vol. 29 
